IGF-1-driven dose reduction community reports describe halving the daily dose if IGF-1 exceeds the lab's upper reference limit, then re-checking at 4 weeks
These changes can cause gallstones or cholecystitis
MOTS-c is a mitochondrial-derived peptide studied for how it influences glucose use, insulin sensitivity, and fuel flexibility
2 Materials and methods 2.1 Experimental design The experiment was conducted at the experimental station of the Institute of Animal Nutrition, Friedrich-Loeffler-Institute (FLI), in Braunschweig, Germany in accordance with the German Animal Welfare Act and permitted by the Lower Saxony State Office for Consumer Protection and Food Safety (LAVES, Oldenburg, Germany) (AZ33.19-42502-04-16/2378)
See also: Medicare coverage of cardiovascular medications and the ACCESS model
That said, if youve been on a lower or mid-range dose for a while and weight loss has stalled, a dose increase (aka "titrating up") might helpbut its not a guarantee